Unicycive Therapeutics (Nasdaq: UNCY) announced FDA alignment on resolving the single manufacturing deficiency delaying approval of its novel phosphate binder Oxylanthanum Carbonate (OLC). Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at https://b2idigital.com/unicycive. Following constructive discussions with the FDA about resolving the single deficiency identified in June’s Complete Response Letter related to the compliance status of a third-party m

YY Group Holding Limited (Nasdaq: YYGH) announced a strategic update highlighting accelerated momentum in its global expansion and growth initiatives, following its US$4 million registered direct offering completed in September 2025. YY Group is a B2i Digital Featured Company. See its investor profile at https://b2idigital.com/yy-group. The Company’s strategic investments are transforming its business model by globalizing its on-demand staffing network through YY Circle and evolving its janitori